EXMCeuticals Inc. provides Corporate Update
September 10, 2019 09:00 ET
|
EXMceuticals Inc.
VANCOUVER, British Columbia, Sept. 10, 2019 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a cultivator and producer of cannabis extractions and refined...
CB2 Insights Announces Appointment of Medical Director in Colombia and Enters Market with Cannabis Research Focus
September 03, 2019 08:20 ET
|
CB2 Insights
Company recruits prominent Colombian naturopathic and integrative medicine physician Dr. Paola Cubillos, MD, ND to lead medical cannabis research programs to advance emerging marketRapid growth in...
CB2 Insights to Host Q2 2019 Earnings Call on August 28, 2019
August 20, 2019 16:35 ET
|
CB2 Insights
TORONTO, Aug. 20, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII; OTCQB:CBIIF), a leading data-driven company focused on bringing real-world evidence driven from the...
EXMceuticals Inc. appoints cannabis industry leader Tripp Keber as Strategic Advisor to the Board
August 20, 2019 09:00 ET
|
EXMceuticals Inc.
VANCOUVER, British Columbia, Aug. 20, 2019 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a cultivator and producer of high-grade cannabis extracted...
CB2 Insights Announces New Appointment to Board of Directors with Medical Cannabis and Capital Markets Executive
August 01, 2019 08:00 ET
|
CB2 Insights
TORONTO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...
CB2 Insights Adds Former Johnson & Johnson Executive as Director
July 31, 2019 08:00 ET
|
CB2 Insights
TORONTO, July 31, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...
CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot
July 18, 2019 07:11 ET
|
CB2 Insights
NEWS HIGHLIGHTS CB2 Insights has been selected as exclusive research technology platform for the UK’s largest medical cannabis Pilot - Project TWENTY21Project TWENTY21 aims to enroll 20,000 patients...
CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot
July 18, 2019 07:11 ET
|
CB2 Insights
NEWS HIGHLIGHTS CB2 Insights has been selected as exclusive research technology platform for the UK’s largest medical cannabis Pilot - Project TWENTY21Project TWENTY21 aims to enroll 20,000 patients...
CB2 Insights and Premier Health Group Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluations
July 09, 2019 07:30 ET
|
CB2 Insights
TORONTO, July 09, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIT) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...
CB2 Insights Expands Clinical Division into New Jersey with the Asset Acquisition of New Jersey Alternative Medicine Clinics
June 25, 2019 07:30 ET
|
CB2 Insights
TORONTO, June 25, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...